← Evidence map

ArticleCell2022

Relatlimab and nivolumab in the treatment of melanoma.

Lewis Au et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

9 papers cite it

2022
2023
2024
2025
2026
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 36563660